Reframing menopause and menopause hormone therapy as opportunities for healthy aging
Science · 01.10.2026 · 394 (6819) · 60-68
DOI: 10.1126/science.aeg5004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science, erschienen am 01.10.2026. Verfasst von Laura L Gravelsins und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Addiction and Mental Health, Toronto, Canada. Hauptthemen laut MEDLINE: Estrogen Replacement Therapy, Healthy Aging, Menopause, Women's Health. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 199 Literaturangaben.
Abstract (Originalsprache)
Menopause is an important biological transition with up to 72 symptoms that shapes aging trajectories across organs and encompasses ~40% of the female lifespan. Although menopause awareness is increasing, research on strategies for menopause symptom management and optimizing health in the postmenopausal period is lacking. This Review highlights that menopause characteristics, such as type, timing, and symptom burden, influence health outcomes and later-life disease risk. Similarly, menopause hormone therapy comes in >200 varieties that differ by dose, formulation of estrogens and progestogens, and timing, each with their own distinct risk-benefit profiles. These distinctions are often missed in the literature but have considerable repercussions for outcomes. Optimized menopause care necessitates a precision medicine approach that considers menopause symptoms, genetics, and previous hormone exposures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Addiction and Mental Health, Toronto, Canada.
- Rehabilitation Sciences Institute, University of Toronto, Toronto, Canada.
- Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Canada.
ORCID-Profile: Laura L Gravelsins, Mateja Perović, Madeline Wood Alexander, Andrew J McGovern, Jennifer S Rabin, Liisa A M Galea
Zitieren
APA
Gravelsins, L. L., Perović, M., Alexander, M. W., Splinter, T. F. L., McGovern, A. J., Rabin, J. S., & Galea, L. A. M. (2026). Reframing menopause and menopause hormone therapy as opportunities for healthy aging. Science, 394(6819), 60-68. https://doi.org/10.1126/science.aeg5004
Vancouver
Gravelsins LL, Perović M, Alexander MW, Splinter TFL, McGovern AJ, Rabin JS, et al. Reframing menopause and menopause hormone therapy as opportunities for healthy aging. Science. 2026;394(6819):60-68. doi:10.1126/science.aeg5004
BibTeX
@article{Gravelsins2026,
author = {Gravelsins, Laura L and Perović, Mateja and Alexander, Madeline Wood and Splinter, Tallinn F L and McGovern, Andrew J and Rabin, Jennifer S and Galea, Liisa A M},
title = {Reframing menopause and menopause hormone therapy as opportunities for healthy aging},
journal = {Science},
year = {2026},
volume = {394},
number = {6819},
pages = {60--68},
doi = {10.1126/science.aeg5004}
}
EUVIMED